Moxonidine and Ramipril in Patients with Hypertension and Obstructive Pulmonary Disease

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.20, Iss.1, 2000-07, pp. : 19-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease: Advances in Pathophysiology and Management

By > Blanco Isabel

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1153-1171

Adis International

Access to resources Recommend Favorite

Effects of Losartan on the Renin-Angiotensin-Aldosterone System and Erythrocytosis in Patients with Chronic Obstructive Pulmonary Disease and Systemic Hypertension

By Füsun ülger A.

Clinical Drug Investigation, Vol. 21, Iss. 5, 2001-01 ,pp. : 337-343

Adis International

Access to resources Recommend Favorite

Management of Insomnia in Patients With Chronic Obstructive Pulmonary Disease

By George C.F.P.

Drugs, Vol. 63, Iss. 4, 2003-01 ,pp. : 379-387

Adis International

Access to resources Recommend Favorite

Once-Daily Nebivolol 5mg Does Not Reduce Airway Patency in Patients with Chronic Obstructive Pulmonary Disease and Arterial Hypertension: A Placebo-Controlled Crossover Study

By dal Negro R.W. Tognella S. Pomari C.

Clinical Drug Investigation, Vol. 22, Iss. 6, 2002-06 ,pp. : 361-367

Adis International

Access to resources Recommend Favorite

Effect of Ramipril on Endothelial Dysfunction in Patients with Essential Hypertension

By Fang L.

Clinical Drug Investigation, Vol. 22, Iss. 7, 2002-07 ,pp. : 449-453

Adis International

Access to resources Recommend Favorite